Jill Zachary K. D. Sadritdin Gretta Sharon Barbara Case Ashman Sagawa Tait Ishmukhamedov Blatner Sut

The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial

R. Walker, R. Coler, S. Reed, 2018, npj Vaccines.

The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial

R. Walker, R. Coler, S. Reed, 2018, npj Vaccines.